Blueprint Medicines Corp (NASDAQ:BPMC)

100.17
Delayed Data
As of Oct 21
 -2.30 / -2.24%
Today’s Change
43.29
Today|||52-Week Range
105.50
+25.04%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$5.7B

Company Description

Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Contact Information

Blueprint Medicines Corp.
45 Sidney Street
Cambridge Massachusetts 02139
P:(617) 374-7580
Investor Relations:
(617) 714-6674

Employees

Shareholders

Mutual fund holders53.22%
Other institutional48.34%
Individual stakeholders10.49%

Top Executives

Jeffrey W. AlbersPresident, Chief Executive Officer & Director
Kathryn HavilandChief Operating Officer
Michael LandsittelChief Financial Officer
Anthony L. BoralChief Medical Officer
Marion DorschChief Scientific Officer